Certara

Meet Himanshu M., Director of Business Development! At #SOT2025, he's showcasing #SecondaryIntelligence, #Simcyp PBPK Simulator & #Libra. ?? Hear his insights & catch up on the Simcyp V24 webinar: https://lnkd.in/ekpJA_37 Visit Booth #1147 to chat! #Simcyp #PBPK #Toxicology

It’s been an exciting day at #PHUSE US Connect! After a full day of engaging presentations, we’re now showcasing two posters during the Poster Session, which runs until 7 PM today! 1?? Elevate Your Game: Leveling Up SDTM Validation with the Magic of Data Managers 2?? Optimizing AI Software for Automated Protection of Personal and Commercially Sensitive Data If you're here, stop by and check out the work our team has been doing — we’d love to chat and answer any questions you may have! Don’t miss the chance to connect with us before the session wraps up!

?? SOT is buzzing! ?? Michael Miner caught up with Joyce (Chandler) Zandee on her event highlights. ?? Visit Booth #1147 to meet the team & get an exclusive look at the new SEND Explorer for data visualization! #SOT2025 #SENDExplorer #DataVisualization #Toxicology #Simcyp #Libra #CardiacSafety

?? Meet Marc Bailie! He’s been attending #SOT2025 and Michael Miner caught up with him to hear what he’s been up to at the event. If you are at SOT, swing by ?????????? ???????? to chat with Marc and the rest of our team. Don’t miss out on the opportunity to connect! See you there! #SOT2025 #Toxicology #SENDExplorer #Datasets

Join our upcoming Cambridge Healthtech Institute (CHI) webinar to discover how AI accelerates model development and enriches data, leading to more accurate model validation and faster decision-making. Certara experts Fran Brown, Piet Van Der Graaf, Ayman Akil, and Ian Kerman will explore AI's growing role in pharmaceutical development. From building models and linking to clinical endpoints, to applications of AI and regulatory insights, learn how to accelerate your drug development pipeline. ?? Register Now: https://lnkd.in/drJjyDvF #DrugDevelopment #AIinPharma #PharmaceuticalInnovation #Webinar #CambridgeHealthInstitute

Day 2 of SOT 2025 is off to an exciting start! We kicked off the day with a well-attended session where our very own Barira Islam teamed up with Sylvia. Escher (RISK-HUNT3R) and Nynke Kramer (ONTOX) to dive into the Challenges of NAM-Based Toxicokinetic Assessment in Regulatory Risk Assessment. They shared cutting-edge insights from ASPIS cluster research and a recent European Chemicals Agency project, including a tiered testing strategy within the ASPIS-initiated Alternative Safety Profiling Algorithm (ASPA). Check out these photos from yesterday and the energy our team brought to the conference! ???? #SOT2025 #NAMs #Toxicology #RiskAssessment #ASPIS #Innovation #Teamwork

Day 1 at #DIAEurope was packed with innovation and collaboration! Great discussions on how Certara streamlines the path to regulatory submissions, insightful sessions, and plenty of live demos of CoAuthor and GlobalSubmit in action. Best of all? The conversations around the power of a synergistic relationship between services and software—a key to successful regulatory approvals. Excited for the insights, connections, and breakthroughs still to come over the next few days! #RegulatorySubmissions #Certara #Innovation #LifeSciences

Early-stage drug development is full of challenges—but strategic Chemistry, Manufacturing, and Controls (CMC) and Physiologically Based Pharmacokinetic (PBPK) modeling can significantly reduce risks and accelerate progress. In our latest blog, we explore how integrating these approaches early can improve decision-making, optimize formulations, and streamline regulatory pathways. Don’t leave success to chance—discover how to make smarter, data-driven choices from the start. Read more: https://ow.ly/UZTZ50UTnvA #DrugDevelopment #PBPK #CMC #PharmaInnovation #Certara

?? Only 1 week left! Register now to learn how you can modernize your patient narrative writing ?? Join us on Wednesday, March 26th at 10 AM ET/ 2 PM GMT for an exclusive webinar on how cutting-edge technology is modernizing patient narrative writing. Discover how automation is saving time, reducing complexity, and enhancing accuracy for medical and regulatory teams. Key Takeaways: ? Explore how technology can assist in patient narratives ? Learn how to automate and scale the narrative creation process ? See practical applications of automation through a real-world case study ? Gain actionable insights to simplify your regulatory writing processes Our expert speakers, Reema SelvaRaju and Christopher Kutzler, will share their knowledge, providing fresh perspectives and innovative strategies to empower your team. ?? Reserve your spot today and unlock the future of patient narrative writing: https://lnkd.in/eXMreYHC #MedicalWriting #PatientNarratives #RegulatoryWriting #Innovation

With a strong background in biopharmaceutics and biorelevant in vitro testing, along with extensive experience as project lead in DMPK and clinical pharmacology, Chara Litou contributes valuable expertise to the PBPK Consultancy team at Simcyp. ? Working in the PBPK field for over 7 years, Chara is passionate about developing PBPK-PD models that enhance and streamline drug product development, particularly during clinical phases. She is a strong advocate for biopharmaceutics, with a recognized presence in the biopharmaceutics community.?Chara emphasizes the value of integrating PBPK models, along with efficient clinical pharmacology strategy, to achieve optimal outcomes and support a deeper mechanistic understanding of drugs and drug products, for the benefit of patients. Learn more about our Simcyp PBPK services: https://lnkd.in/eAiyUyzV